Cabotegravir is a long-acting HIV integrase inhibitor that is injected every two months for the treatment or prevention of HIV. It is a highly effective medication, and its long-acting formulation makes it a convenient option for many people living with or at risk of HIV.

Cabotegravir is currently only available from a single manufacturer, which means that it is expensive for many people. The lack of a generic source is especially concerning for people in low- and middle-income countries, where the need for cabotegravir is greatest.